Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.

Conditions: Opioid Use Disorder Interventions: Drug: Methadone; Drug: Buprenorphine (BUP) Sponsors: Yale University; National Institutes of Health (NIH); National Institute on Drug Abuse (NIDA); The Emmes Company, LLC; University of California, San Francisco; Boston Medical Center (BMC); Hennepin Healthcare Research Institute; Alameda Health System; Marshall Health; Kaiser Permanente Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials